A. Szabo

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G. | Psychopharmacology | 10 December 2019

By OPEN|2020-02-24T19:55:21+02:0010 December 2019|Tags: A. Davis, A. Szabo, J. Ramaekers, J. Riba, M. Uthaug, R. Lancelotta|

Weak phantasy and visionary phantasy: the phenomenological significance of altered states of consciousness

Horváth, L., Szummer, C., & Szabo, A. | Phenomenology and the Cognitive Sciences | 6 January 2017

By OPEN|2017-04-03T11:35:28+02:006 January 2017|Tags: A. Szabo, C. Szummer, L. Horváth|

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells

Szabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. | Frontiers in Neuroscience | 14 September 2016

By OPEN|2016-09-18T13:12:19+02:0014 September 2016|Tags: A. Kovacs, A. Szabo, E. Frecska, E. Rajnavolgyi, J. Riba, S. Djurovic|

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

Szabo, A., & Frecska, E. | Neural Regeneration Research | 1 April 2016

By OPEN|2016-04-14T20:21:49+02:001 April 2016|Tags: A. Szabo, E. Frecska|

[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca]

Szabo, A., Kazai, A., Frecska, E., & Brys, Z. | official journal of the Hungarian Association of Psychopharmacology | 17 September 2015

By OPEN|2015-11-02T11:56:04+02:0017 September 2015|Tags: A. Kazai, A. Szabo, E. Frecska, Z. Brys|

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

Szabo, A. | Frontiers in Immunology | 14 July 2015

By OPEN|2017-06-11T13:27:38+02:0014 July 2015|Tags: A. Szabo|

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

Szabo, A. | Frontiers in Immunology | 14 July 2015

By OPEN|2017-06-11T13:27:38+02:0014 July 2015|Tags: A. Szabo|

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells

Szabo, A., Kovacs, A., Frecska, E., & Rajnavolgyi, E. | PloS ONE | 29 August 2014

By OPEN|2015-01-07T23:38:53+02:0029 August 2014|Tags: A. Kovacs, A. Szabo, E. Frecska, E. Rajnavolgyi|

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity

Frecska, E., Szabo, A., Winkelman, M. J., Luna, L. E., & McKenna, D. J. | Journal of Neural Transmission | 26 April 2013

By OPEN|2014-12-31T12:51:10+02:0026 April 2013|Tags: A. Szabo, D. McKenna, E. Frecska, L. Luna, M. Winkelman|